Related Experiment Videos
NMDA receptor antagonist MK-801 down-regulates rat striatal proenkephalin and protachykinin mRNAs
F Zhang1, L Van Bree, N Albala
1Brain Research Unit and Laboratory of Neuropathology and Neuropeptide Research, Université Libre de Bruxelles, Belgium.
Abstract:
Using quantitative in situ hybridization, a significant decrease in expression of proenkephalin (27.1%) and of protachykinin mRNAs (20.0%) is observed in the rat caudate-putamen 14 days after daily intraperitoneal administration of N-methyl-D-aspartate receptor antagonist MK-801, 2 mg/kg.
Insights
Daily administration of the N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 significantly reduced proenkephalin and protachykinin mRNA expression in the rat caudate-putamen. These findings suggest MK-801 impacts key neuropeptide systems in the brain.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- The N-methyl-D-aspartate (NMDA) receptor is crucial for synaptic plasticity and learning.
- NMDA receptor antagonists, like MK-801, are used to study glutamatergic neurotransmission.
- Proenkephalin and protachykinin are neuropeptides involved in various brain functions.
Purpose of the Study:
- To investigate the effects of chronic MK-801 administration on neuropeptide mRNA expression in the rat brain.
- To quantify changes in proenkephalin and protachykinin mRNA levels in the caudate-putamen.
Main Methods:
- Quantitative in situ hybridization was employed to measure mRNA levels.
- Rats received daily intraperitoneal injections of MK-801 (2 mg/kg) for a specified duration.
- Gene expression was analyzed in the caudate-putamen region of the brain.
Main Results:
- A significant decrease in proenkephalin mRNA expression (27.1%) was observed.
- Protachykinin mRNA expression also showed a significant reduction (20.0%).
- These changes were evident 14 days after the initiation of MK-801 treatment.
Conclusions:
- Chronic administration of the NMDA receptor antagonist MK-801 downregulates proenkephalin and protachykinin gene expression in the rat caudate-putamen.
- These findings highlight the impact of NMDA receptor blockade on endogenous opioid and tachykinin systems.
- Further research is warranted to understand the functional consequences of these molecular changes.